|
CN112129938A
|
|
Application of UDP-Glc in lung cancer metastasis assessment
|
|
CN112121167A
|
|
Application of UDP-Glc in preparation of medicine for inhibiting lung cancer metastasis
|
|
CN112107684A
|
|
Methods and compositions for treating ARID2 or HSPA1A mediated diseases
|
|
CN112047848A
|
|
Dopamine D2Receptor selective agonists and uses thereof
|
|
CN111939259A
|
|
Na/K-ATPase inhibitor and application thereof
|
|
CN111603477A
|
|
Application of circular RNA in preparation of therapeutic drugs for systemic lupus erythematosus
|
|
CN111434769A
|
|
Preparation method and application of exosome
|
|
CN111435138A
|
|
Pancreatic cancer protein biomarker and application thereof
|
|
CN111423507A
|
|
Fully human antibodies that neutralize influenza viruses in a broad spectrum
|
|
CN111346215A
|
|
Application of candida albicans secreted cysteine-rich protein Sel1
|
|
CN111304147A
|
|
Method for preparing functional bile duct cells in large scale by using endoderm stem cells and application thereof
|
|
CN111166867A
|
|
Function and use of PD-1 ubiquitination agonist
|
